1B1 — Hc Surgical Specialists Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapContrarian
- SG$52.11m
- SG$47.33m
- SG$19.08m
- 81
- 61
- 38
- 68
Annual balance sheet for Hc Surgical Specialists, fiscal year end - May 31st, SGD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.03 | 6.79 | 11 | 6.93 | 10.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2 | 1.38 | 2.85 | 1.56 | 1.75 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.67 | 8.96 | 14.4 | 9.12 | 12.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.1 | 4.49 | 4.87 | 3.88 | 4.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 26.6 | 30.4 | 36.3 | 31 | 31.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.69 | 4.39 | 7.68 | 7.65 | 11.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.74 | 14.1 | 26.5 | 20 | 19.2 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 19.9 | 16.3 | 9.83 | 11 | 12.1 |
| Total Liabilities & Shareholders' Equity | 26.6 | 30.4 | 36.3 | 31 | 31.3 |
| Total Common Shares Outstanding |